The increase of miR-139–5p greatly inhibits the expression of SOX5 in prostate cancer cells, down-regulates TWIST, and reduces the expression of N-cadherin and vimentin, thereby inhibiting the EMT process and thus inhibiting the cell proliferation and cell migration of prostate cancer cells (57). This evidence concerns the gene SOX5 and Familial prostate cancer.